Результати пошуку - Boland, M.R.
- Показ 1 - 8 результатів із 8
-
1
-
2
Does Mode of Surgical Intervention Based on Oncotype DX Score Influence Disease Recurrence in Early Breast Cancer? за авторством Aherne, T. M., Boland, M. R., Catargiu, D., Bashar, K., McVeigh, T. P., Brodie, C., Sweeney, K. J.
Опубліковано 2020Текст -
3
Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis за авторством Davey, M.G., Ryan, É.J., Boland, M.R., Barry, M.K., Lowery, A.J., Kerin, M.J.
Опубліковано 2021Текст -
4
-
5
Incidental Phaeochromocytoma on Staging PET-CT in a Patient with a Sigmoid Tumour and Situs Inversalis Totalis за авторством Boland, M. R., Lowery, A. J., Walsh, S., Beddy, D., Prichard, R. S., O'Shea, D., Skehan, S. J., McDermott, E. W.
Опубліковано 2014Текст -
6
Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis за авторством Davey, M G, Davey, M S, Ryan, É J, Boland, M R, McAnena, P F, Lowery, A J, Kerin, M J
Опубліковано 2021Текст -
7
Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy за авторством Boland, M. R., McVeigh, T. P., O'Flaherty, N., Gullo, G., Keane, M., Quinn, C. M., McDermott, E. W., Lowery, A. J., Kerin, M. J., Prichard, R. S.
Опубліковано 2017Текст -
8
The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer за авторством Davey, M G, Ryan, É J, Folan, P J, O’Halloran, N, Boland, M R, Barry, M K, Sweeney, K J, Malone, C M, McLaughlin, R J, Kerin, M J, Lowery, A J
Опубліковано 2021Текст